Literature DB >> 11417240

[Long-term results with the cement-free Spotorno CLS shaft].

R Siebold1, G Scheller, U Schreiner, L Jani.   

Abstract

This retrospective study reviews 298 sequential cementless CLS Spotorno stems, which achieved their primary fixation and bony in- or ongrowth predominantly in the metaphyseal region. The minimum follow-up was 10 years and the average follow-up 11.7 years (range 10-14). The mean age at surgery was 55.2 years (range 32.2-68.9). Of the patients, 76.2% (227 stems) were followed up: 172 patients (57.7%) underwent clinical and radiological examination and 52 patients (55 stems, 18.5%) were interviewed by telephone. Of 298 stems, 13 (4.4%) had been replaced in the mean time, only 6 stems (2.0%) because of an aseptic loosening. The evaluation included both clinical (Merle d'Aubigne and Harris hip score) and radiographic parameters (plain X-rays). The mean Merle d'Aubigne score was 16.7 points, and the mean Harris hip score was 94.3 points. Radiolucent lines were detected in 33.7%; 5.8% showed enlargement within the last 3 years. Focal osteolyses were present in 30.8% of patients; 2.9% had progressed within the last 3 years. At follow-up, one patient presented with new clinical and radiological evidence of aseptic stem loosening. The current study showed an aseptic loosening of the CLS stem in 2.3%, a good osseointegration and good functional score results in more than 90%. The primary fixation and bony in- or ongrowth predominantly in the metaphyseal region seems to achieve good clinical results. Wear is the main reason for the osteolytic changes. Frequent clinical and radiological follow-up is important to detect bone reactions and loosening of the stem.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11417240     DOI: 10.1007/s001320050614

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  8 in total

1.  Survival of the cementless Spotorno stem in the second decade.

Authors:  Peter R Aldinger; Alexander W Jung; Steffen J Breusch; Volker Ewerbeck; Dominik Parsch
Journal:  Clin Orthop Relat Res       Date:  2009-06-06       Impact factor: 4.176

2.  Pooled outcome of total hip arthroplasty with the CementLess Spotorno (CLS) system: a comparative analysis of clinical studies and worldwide arthroplasty register data.

Authors:  Patrick Sadoghi; Wolfgang Janda; Mark Agreiter; Rauend Rauf; Andreas Leithner; Gerold Labek
Journal:  Int Orthop       Date:  2013-03-24       Impact factor: 3.075

Review 3.  [Pain symptoms of osteoarthritis-aspects of etiology and therapy].

Authors:  L Lehmann; J Stöve
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

4.  Long-term (20- to 25-year) results of an uncemented tapered titanium femoral component and factors affecting survivorship.

Authors:  Marcus R Streit; Moritz M Innmann; Christian Merle; Thomas Bruckner; Peter R Aldinger; Tobias Gotterbarm
Journal:  Clin Orthop Relat Res       Date:  2013-05-14       Impact factor: 4.176

5.  [Femoral neck prostheses].

Authors:  C Stukenborg-Colsman
Journal:  Orthopade       Date:  2007-04       Impact factor: 1.087

Review 6.  [Uncemented arthroplasty of the hip].

Authors:  C von Schulze Pellengahr; A Fottner; S Utzschneider; M Schmitt-Sody; W Teske; T Lichtinger; S A Esenwein
Journal:  Orthopade       Date:  2009-05       Impact factor: 1.087

7.  Mid-term results of an uncemented tapered femoral stem and various factors affecting survivorship.

Authors:  Mayank Vijayvargiya; Vivek Shetty; Kiran Makwana; Harpreet Singh Suri
Journal:  J Clin Orthop Trauma       Date:  2018-02-05

Review 8.  Early subsidence of shape-closed hip arthroplasty stems is associated with late revision. A systematic review and meta-analysis of 24 RSA studies and 56 survival studies.

Authors:  Paul van der Voort; Bart G Pijls; Marc J Nieuwenhuijse; Jorrit Jasper; Marta Fiocco; Josepha W M Plevier; Saskia Middeldorp; Edward R Valstar; Rob G H H Nelissen
Journal:  Acta Orthop       Date:  2015       Impact factor: 3.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.